Back to top
more

Jazz Pharmaceuticals (JAZZ)

(Delayed Data from NSDQ)

$254.28 USD

254.28
516,638

+5.58 (2.24%)

Updated Aug 21, 2026 04:00 PM ET

After-Market: $254.09 -0.19 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (151 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kevin Cook headshot

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

by Kevin Cook

Trading at just 11X next year's $13 EPS, this innovator is just getting started fighting cancer with new FDA approvals and partnerships

    Zacks Equity Research

    Zacks.com featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group

    by Zacks Equity Research

    Zacks.com featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group

      Zacks Equity Research

      Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule

      by Zacks Equity Research

      ImmunoGen (IMGN) and Jazz Pharma announced a strategic collaboration to develop and commercialize antibody-drug conjugate products.

        Zacks Equity Research

        ImmunoGen (IMGN) in Focus: Stock Moves 17.3% Higher

        by Zacks Equity Research

        ImmunoGen (IMGN) was a big mover last session, as the company saw its shares rise over 17% on the day amid huge volumes.

          Zacks Equity Research

          5 Excellent Value Stocks Based on Low PEG Ratio

          by Zacks Equity Research

          While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.

            Zacks Equity Research

            Enanta Pharmaceuticals (ENTA) Looks Good: Stock Adds 9.6% in Session

            by Zacks Equity Research

            Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session, as the company saw its shares rise over 9% on the day.

              Zacks Equity Research

              Ironwood Pharma's Combination Gout Drug Gets FDA Approval

              by Zacks Equity Research

              Ironwood Pharmaceuticals, Inc. (IRWD) announced that the FDA has approved Duzallo for the treatment of hyperuricemia in patients with uncontrolled gout.

                Swarup Gupta headshot

                Rally Set to Resume: Buy These 5 Value Picks on the Dip

                by Swarup Gupta

                Morgan Stanley believes that conditions for a Bull Run remain in place.

                  Zacks Equity Research

                  Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer

                  by Zacks Equity Research

                  Jazz Pharmaceuticals (JAZZ) announces private offering of exchangeable senior notes to qualified institutional buyers to raise proceeds and repay debt.

                    Zacks Equity Research

                    Endo International (ENDP) Jumps: Stock Rises 6.9%

                    by Zacks Equity Research

                    Endo International (ENDP) was a big mover last session, as the company saw its shares rise almost 7% on the day amid huge volumes.